RP, a rare disease
RP, a rare disease
There are 300 million people worldwide living with a rare disease. In Germany alone there are around 4 million. Most of the more than 6,000 different rare diseases are of genetic origin. Retinitis pigmentosa (RP) is one of them.
About one in 4,000 people is affected. There are therapies for only about 3% of rare diseases – the OkuStim therapy for RP is one of them. It can preserve your vision.
We are continuously working to make the OkuStim therapy more accessible. We are expanding our network – now also in Great Britain. Your feedback on the OkuStim therapy is our motivation to continue working for the treatment of rare diseases.
Best wishes,
Okuvision
New Competence Centre London
New Competence Centre London
OkuStim Therapy now also in UK
The OkuStim therapy for retinitis pigmentosa is now also available for you in Great Britain.
Your contact at the Harley Street Eye Centre is Dr. Hakam Ghabra.
22A Harley Street
London W1G 9BP, UK
Dr. Hakam Ghabra
Email: info@eyesat22a.com
Tel.: +44 (0) 20 3968 2030
Mob.: +44 (0) 750 232 0504
Transcorneal electrical stimulation (TES) with OkuStim is the only available topically applied treatment for retinitis pigmentosa with clinically proven safety and efficacy. OkuStim therapy can slow the disease and progressive loss of visual field.